Participating countries

In Europe, female patients will be included in the MyPeBS trial in France, Italy, Belgium, and the United Kingdom, as well as in Israel, which participates in European research programmes. Furthermore, cross-country analyses are planned with the American study Wisdom which includes 100,000 women.

risque individu